Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
IN

INCY

Market Closed

Incyte Corporation

NASDAQHealthcareBiotechnology
US
2.84K employees
CEO: William J. Meury
Founded: 1993
$121.04
+$0.00(+NaN%)
Market Cap
24.67B
Beta
0.78
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Incyte’s current price aligns closely with its fair value, indicating fair valuation amid high confidence. Robust financial health contrasts with wide Monte Carlo volatility and significant downside risk (77.8%), signaling pronounced valuation uncertainty and potential investment risk. EV/EBITDA suggests upside opportunity, contrasting more conservative DCF and analyst targets.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore INCY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

INCY in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →